101 related articles for article (PubMed ID: 2677628)
1. Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study Group.
Buckley JD; Lampkin BC; Nesbit ME; Bernstein ID; Feig SA; Kersey JH; Piomelli S; Kim T; Hammond GD
Med Pediatr Oncol; 1989; 17(5):382-90. PubMed ID: 2677628
[TBL] [Abstract][Full Text] [Related]
2. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
3. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
[TBL] [Abstract][Full Text] [Related]
5. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
[TBL] [Abstract][Full Text] [Related]
6. High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group.
Lazarus HM; Vogler WR; Burns CP; Winton EF
Cancer; 1989 Mar; 63(6):1055-9. PubMed ID: 2917307
[TBL] [Abstract][Full Text] [Related]
7. Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
Stein RS; Vogler WR; Winton EF; Cohen HJ; Raney MR; Bartolucci A
Leuk Res; 1990; 14(10):895-903. PubMed ID: 2259226
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
9. Daunorubicin 90 mg/m
Portugal R; Lyrio R; Loureiro M; Urago K; Bard J; Borchardt A; Garnica M; Nucci M
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):527-531. PubMed ID: 28842139
[TBL] [Abstract][Full Text] [Related]
10. Intensive treatment of acute leukemia in adults 70 years of age and older.
Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.
Reiffers J; Huguet F; Stoppa AM; Molina L; Marit G; Attal M; Gastaut JA; Michallet M; Lepeu G; Broustet A; Pris J; Maraninchi D; Hollard D; Fabères C; Mercier M; Hurteloup P; Danel P; Tellier Z; Berthaud P
Leukemia; 1996 Mar; 10(3):389-95. PubMed ID: 8642852
[TBL] [Abstract][Full Text] [Related]
12. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study.
Ravindranath Y; Steuber CP; Krischer J; Civin CI; Ducore J; Vega R; Pitel P; Inoue S; Bleher E; Sexauer C
J Clin Oncol; 1991 Apr; 9(4):572-80. PubMed ID: 2066754
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide.
Liang R; Chiu E; Chan TK; Todd D
Cancer Chemother Pharmacol; 1990; 26(5):380-2. PubMed ID: 2208581
[TBL] [Abstract][Full Text] [Related]
14. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group.
Br J Haematol; 1998 Oct; 103(1):100-9. PubMed ID: 9792296
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Vogler WR; Winton EF; Gordon DS; Raney MR; Go B; Meyer L
Blood; 1984 May; 63(5):1039-45. PubMed ID: 6201211
[TBL] [Abstract][Full Text] [Related]
17. Combination of rubidazone and cytosine arabinoside in the treatment of first relapse in acute myelocytic leukemia.
Pavlovsky S; Fernández I; Palau V; Santarelli MT; De Bellis R; Ruiz-Argüelles G; Brandalise S; Jiménez-Fonseca E
Ann Oncol; 1991 Jun; 2(6):441-2. PubMed ID: 1768631
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome.
Bow EJ; Kilpatrick MG; Scott BA; Clinch JJ; Cheang MS
Cancer; 1994 Jul; 74(1):52-60. PubMed ID: 8004583
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
Amadori S; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Covelli A; Mandelli F
J Clin Oncol; 1987 Sep; 5(9):1356-63. PubMed ID: 3476689
[TBL] [Abstract][Full Text] [Related]
20. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]